Kt. Christov et al., CELL-PROLIFERATION AND APOPTOSIS DURING MAMMARY CARCINOGENESIS IN PITUITARY ISOGRAFTED MICE, Carcinogenesis, 17(8), 1996, pp. 1741-1746
In the present study, pituitary isografted animals serve as a model fo
r evaluating the changes in differentiation, cell proliferation and pr
ogrammed cell death (apoptosis) in mammary epithelial cells during car
cinogenesis, The percentage of bromodeoxyuridine (BrdU)-labeled ductal
and alveolar cells was significantly higher in pituitary isografted a
nimals than in non-isografted control animals, BrdU-labeled cells incr
eased in lobular hyperplastic nodules, keratinized nodules and mammary
carcinomas; similar changes were observed with apoptotic cells, which
were rare in mammary glands of adult non-isografted animals (one to t
hree apoptotic cells per 2000 mammary epithelial cells), but their num
ber increased in hyperplastic lesions and mammary carcinomas, Among hy
perplastic nodular lesions, variants with high, moderate and low proli
ferative activity and/or apoptotic cell death were identified, which s
uggests that they may have different growth potentials and different p
ropensities for malignant transformation. After removing pituitary iso
grafts, apoptosis occurs in hyperplastic lesions but not in mammary ca
rcinomas - implying that malignant tumors are hormone-independent. The
dynamics of the changes in apoptotic cell death among various hyperpl
astic lesions after removal of pituitary isografts suggests that these
lesions are composed of heterogeneous cell populations, as far as the
initiation of apoptosis is concerned, Our data indicate that apoptosi
s can be used together with cell proliferation as a potential marker i
n characterizing the growth potential and phenotypic diversity of hype
rplastic, premalignant and malignant mammary gland lesions.